Company Filing History:
Years Active: 1978-1990
Title: The Innovations of Louis Lemberger
Introduction
Louis Lemberger is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of 5 patents to his name, Lemberger's work has had a meaningful impact on the industry.
Latest Patents
Lemberger's latest patents include a method for selectively blocking 5-HT.sub.2 receptors. This invention relates to the use in vivo of 1-isopropyldihydrolysergic acid as a 5-HT.sub.2 antagonist. Another significant patent involves hexahydro-dibenzo[b,d]pyran-9-ones as anticonvulsant drugs, which utilizes 1-hydroxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones for treating convulsions.
Career Highlights
Lemberger is currently employed at Eli Lilly and Company, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Lemberger has collaborated with esteemed colleagues such as Robert A Archer and Marlene L Cohen. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Louis Lemberger's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medical treatments and technologies.